in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Shasun and SeQuent to form leading animal health joint venture
July 13, 2013 | Natasha Alperowicz
Shasun Pharmaceuticals (Chennai, India) and SeQuent Scientific (Bangalore, India) have signed a letter of intent (LOI) to form a joint venture to develop, manufacture, and sell veterinary products, including active pharmaceutical ingredients and formulations in the global market, the companies announced today. SeQuent, and integrated pharmaceuticals company, will hold 73% in the jv and Shasun will have the balance. The establishment of the jv is subject to corporate and statutory approvals with operations expected to begin in the first quarter of 2014. On...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee